Why Americans Pay So Much for Prescription Drugs

The video discusses the potential impact of allowing drug importation on pharmaceutical companies, focusing on branded and generic drugs. It explores possible legislation to control drug price increases and compares US drug prices with those in other countries. The role of R&D costs in drug pricing is examined, highlighting the involvement of NIH and venture capital. The concept of Medicare for All and its potential to improve price negotiation is discussed. Finally, the influence of pharmacy benefit managers on drug pricing and formulary decisions is analyzed.

What role do pharmacy benefit managers (PBMs) play in the pricing of drugs?

How does the negotiation process for drug prices in the United States differ from that in other countries?

What are the implications of having multiple entities negotiating drug prices in the U.S.?